Chris Lewis
Stock Analyst at Roth Capital
(3.09)
# 1,289
Out of 4,753 analysts
14
Total ratings
90%
Success rate
57.25%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Chris Lewis
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CGNT Cognyte Software | Reinstates: Buy | $4 | $10.05 | -60.20% | 5 | Nov 8, 2017 | |
| IRMD IRADIMED CORPORATION | Reinstates: Buy | $16 | $61.23 | -73.87% | 3 | Oct 31, 2017 | |
| CUTR Cutera | Initiates: Buy | $32 | $0.44 | +7,204.27% | 1 | Jun 26, 2017 | |
| AXGN Axogen | Initiates: Buy | $15 | $18.08 | -19.80% | 1 | Mar 6, 2017 | |
| EXAS Exact Sciences | Upgrades: Buy | n/a | $54.75 | - | 3 | Feb 22, 2017 | |
| IRIX IRIDEX | Initiates: Buy | $20 | $1.64 | +1,116.92% | 1 | Dec 21, 2016 |
Cognyte Software
Nov 8, 2017
Reinstates: Buy
Price Target: $4
Current: $10.05
Upside: -60.20%
IRADIMED CORPORATION
Oct 31, 2017
Reinstates: Buy
Price Target: $16
Current: $61.23
Upside: -73.87%
Cutera
Jun 26, 2017
Initiates: Buy
Price Target: $32
Current: $0.44
Upside: +7,204.27%
Axogen
Mar 6, 2017
Initiates: Buy
Price Target: $15
Current: $18.08
Upside: -19.80%
Exact Sciences
Feb 22, 2017
Upgrades: Buy
Price Target: n/a
Current: $54.75
Upside: -
IRIDEX
Dec 21, 2016
Initiates: Buy
Price Target: $20
Current: $1.64
Upside: +1,116.92%